OpenAI buys Orchestra Bio, folding it into Rosalind
Partnership
OpenAI has completed its acquisition of Orchestra Bio, a biomedical research collaboration platform, and will integrate it with its existing life sciences AI research platform Rosalind.
The deal, reported by Cailianshe, folds a research collaboration tool into OpenAI's life sciences effort, which already runs Rosalind.
The source gives no purchase price, terms or timeline for the integration.